Clinical trials of thrombolytic agents in myocardial infarction.
D001315:Australia; D002986:Clinical Trials as Topic; D003325:Coronary Care Units; D004739:England; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005387:Finland; D005860:Germany, West; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007558:Italy; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use; D013557:Switzerland; D013997:Time Factors; D014852:Wales
D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase